U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07632157) titled 'MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation' on May 21.
Brief Summary: The purpose of this research study is to find out if the use of magnesium in addition to Metoprolol, a rate controlling medication that you would be offered in the Emergency Department today unrelated to this study, will help reduce your high heart rate (rapid ventricular response).
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Atrial Flutter With Rapid Ventricular Response
Intervention:
DRUG: Magnesium Sulfate 2g
Magnesium Sulfate 2g for the treatment of atrial fibrillation or atrial flutter with rapid ventricular...